Who to call at Passage Bio, and when
Fundz watches for the moments Passage Bio starts buying, and tells you who to reach.
- An alert the day Passage Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Passage Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Passage Bio. With Fundz connected, it knows.
Contract Type
lease_termination
Description
On March 4, 2026, Passage Bio, Inc. and Hopewell Campus Owner LLC finalized a lease termination agreement concerning the Hopewell Lease. The agreement stipulates a termination fee of approximately $4.8 million, including accrued rent until February 14, 2026. The original lease covered about 62,000 square feet of laboratory space
Quick answer
Passage Bio Terminates Lease Agreement with Hopewell Campus Owner LLC (March 10, 2026). Passage Bio is based in United States.
- What agreement did Passage Bio announce on March 10, 2026?
- On March 4, 2026, Passage Bio, Inc. and Hopewell Campus Owner LLC finalized a lease termination agreement concerning the Hopewell Lease. The agreement stipulates a termination fee of approximately $4.8 million, including accrued rent until February 14, 2026.
- What does Passage Bio do?
- Passage Bio, Inc. (NASDAQ: PASG) is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases.
- Where is Passage Bio based?
- Passage Bio is based in United States.
Source: Fundz verified event record.
Related People
Passage Bio signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.